1. Home
  2. GNPX vs JDZG Comparison

GNPX vs JDZG Comparison

Compare GNPX & JDZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$2.02

Market Cap

6.5M

Sector

Health Care

ML Signal

HOLD

JDZG

JIADE LIMITED

HOLD

Current Price

$1.09

Market Cap

5.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
JDZG
Founded
2009
2020
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
5.2M
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
GNPX
JDZG
Price
$2.02
$1.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
274.8K
13.6K
Earning Date
11-14-2025
04-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,680,742.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.19
52 Week Low
$1.99
$1.00
52 Week High
$55.00
$14.00

Technical Indicators

Market Signals
Indicator
GNPX
JDZG
Relative Strength Index (RSI) 33.69 26.06
Support Level $2.51 $1.21
Resistance Level $3.68 $1.28
Average True Range (ATR) 0.29 0.11
MACD -0.09 -0.02
Stochastic Oscillator 1.18 1.82

Price Performance

Historical Comparison
GNPX
JDZG

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About JDZG JIADE LIMITED

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

Share on Social Networks: